Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy.

@article{Wang2013PretreatmentNA,
  title={Pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios do not predict survival in patients with cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy.},
  author={Dan Wang and Ming Wu and Feng-zhi Feng and Huifang Huang and Jia-xin Yang and Keng Shen and Yang Xiang},
  journal={Chinese medical journal},
  year={2013},
  volume={126 8},
  pages={1464-8}
}
BACKGROUND A few inflammatory markers were studied to evaluate their possible prognostic roles in various cancers. The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are hypothesized to reflect the systemic inflammation. The objective of the present study was to investigate whether or not the pretreatment neutrophil-to-lymphocyte ratio or platelet-to-lymphocyte ratio can predict the survival of patients with cervical cancer treated with neoadjuvant chemotherapy and radical… CONTINUE READING